Загрузка...
Growth of Uveal Melanoma following Intravitreal Bevacizumab
PURPOSE: Typically treatment of large melanomas (by Collaborative Ocular Melanoma Study criteria) is restricted to enucleation, due to size constraints for plaque brachytherapy. Because primary and metastatic uveal melanoma cells are inhibited by bevacizumab (an anti-vascular endothelial growth fact...
Сохранить в:
| Опубликовано в: : | Ocul Oncol Pathol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566762/ https://ncbi.nlm.nih.gov/pubmed/28868282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450859 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|